Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow

Molecular Therapy

Volumn 22, Issue 1, 2014, Pages 160-168

  Lin, Paul ^a,b   Correa, Diego ^b   Kean, Thomas J ^c   Awadallah, Amad ^b   Dennis, James E ^c   Caplan, Arnold I ^b  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA ARCH; ARTICLE; BONE MARROW DISEASE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENGRAFTMENT; IMMUNOLOCALIZATION; INTRA ARTERIAL CELL DELIVERY; LONG TERM CARE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROINJECTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; THERAPY EFFECT; VEIN;

MUS;

ANIMALS; BONE MARROW; CELL LINE; GRAFT SURVIVAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MODELS, ANIMAL; WHOLE-BODY IRRADIATION;

EID: 84891824874     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.221     Document Type: Article

References (48)

1. Caplan, AI (1991). Mesenchymal stem cells. J Orthop Res 9: 641-650
2. Meirelles, Lda S, Fontes, AM, Covas, DT and Caplan, AI (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419-427
3. Schenk, S, Mal, N, Finan, A, Zhang, M, Kiedrowski, M, Popovic, Z et al. (2007). Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25: 245-251
4. Li, H, Fu, X, Ouyang, Y, Cai, C, Wang, J and Sun, T (2006). Adult bone-marrowderived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 326: 725-736
5. Chen, J, Li, Y, Wang, L, Zhang, Z, Lu, D, Lu, M et al. (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011
6. Mahmood, A, Lu, D, Qu, C, Goussev, A and Chopp, M (2005). Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery 57: 1026-31; discussion 1026
7. Fouillard, L, Chapel, A, Bories, D, Bouchet, S, Costa, JM, Rouard, H et al. (2007). Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 21: 568-570
8. Mahmood, A, Lu, D, Lu, M and Chopp, M (2003). Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53: 697-702; discussion 702
9. Iso, Y, Spees, JL, Serrano, C, Bakondi, B, Pochampally, R, Song, YH et al. (2007). Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354: 700-706
10. Sorrell, JM, Baber, MA and Caplan, AI (2009). Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 15: 1751-1761
11. Crisan, M, Yap, S, Casteilla, L, Chen, CW, Corselli, M, Park, TS et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313
12. Maes, C, Kobayashi, T, Selig, MK, Torrekens, S, Roth, SI, Mackem, S et al. (2010). Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 19: 329-344
13. Bexell, D, Gunnarsson, S, Tormin, A, Darabi, A, Gisselsson, D, Roybon, L, et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190 (2009).
14. Sacchetti, B, Funari, A, Michienzi, S, Di Cesare, S, Piersanti, S, Saggio, I et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336
15. Weissman, IL (2000). Stem cells: Units of development, units of regeneration, and units in evolution. Cell 100: 157-168
16. Belema-Bedada, F, Uchida, S, Martire, A, Kostin, S and Braun, T (2008). Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2: 566-575
17. Le Blanc, K, Frassoni, F, Ball, L, Locatelli, F, Roelofs, H, Lewis, I et al.; Developmental Committee of the European Group for Blood and Marrow Transplantation. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: A phase II study. Lancet 371: 1579-1586
18. Horwitz, EM, Gordon, PL, Koo, WK, Marx, JC, Neel, MD, McNall, RY et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99: 8932-8937
19. Lee, RH, Pulin, AA, Seo, MJ, Kota, DJ, Ylostalo, J, Larson, BL et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63
20. Schrepfer, S, Deuse, T, Reichenspurner, H, Fischbein, MP, Robbins, RC and Pelletier, MP (2007). Stem cell transplantation: The lung barrier. Transplant Proc 39: 573-576
21. Fischer, UM, Harting, MT, Jimenez, F, Monzon-Posadas, WO, Xue, H, Savitz, SI et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 18: 683-692
22. Tögel, F, Yang, Y, Zhang, P, Hu, Z and Westenfelder, C (2008). Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 295: F315-F321
23. Walczak, P, Zhang, J, Gilad, AA, Kedziorek, DA, Ruiz-Cabello, J, Young, RG et al. (2008). Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39: 1569-1574
24. Lu, SS, Liu, S, Zu, QQ, Xu, XQ, Yu, J, Wang, JW et al. (2013). In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model. PLoS ONE 8: E54963
25. Lin, P, Lin, Y, Lennon, DP, Correa, D, Schluchter, M and Caplan, AI (2012). Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. Stem Cells Transl Med 1: 886-897
26. Jat, PS, Noble, MD, Ataliotis, P, Tanaka, Y, Yannoutsos, N, Larsen, L et al. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci USA 88: 5096-5100
27. Dennis, JE and Caplan, AI (1996). Analysis of the developmental potential of conditionally immortal marrow-derived mesenchymal progenitor cells isolated from the H-2Kb-tsA58 transgenic mouse. Connect Tissue Res 35: 93-99
28. Dennis, JE and Caplan, AI (1996). Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. J Cell Physiol 167: 523-538
29. Dennis, JE, Merriam, A, Awadallah, A, Yoo, JU, Johnstone, B and Caplan, AI (1999). A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14: 700-709
30. Ko, IK, Kim, BG, Awadallah, A, Mikulan, J, Lin, P, Letterio, JJ et al. (2010). Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 18: 1365-1372
31. Phinney, DG, Kopen, G, Isaacson, RL and Prockop, DJ (1999). Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation. J Cell Biochem 72: 570-585
32. Meirelles, Lda S and Nardi, NB (2003). Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. Br J Haematol 123: 702-711
33. François, S, Bensidhoum, M, Mouiseddine, M, Mazurier, C, Allenet, B, Semont, A et al. (2006). Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: A study of their quantitative distribution after irradiation damage. Stem Cells 24: 1020-1029
34. Chapel, A, Bertho, JM, Bensidhoum, M, Fouillard, L, Young, RG, Frick, J et al. (2003). Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 5: 1028-1038
35. Kirkeby, OJ and Berg-Larsen, T (1991). Regional blood flow and strontium-85 incorporation rate in the rat hindlimb skeleton. J Orthop Res 9: 862-868
36. Rajkumar, VS, Shiwen, X, Bostrom, M, Leoni, P, Muddle, J, Ivarsson, M et al. (2006). Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 169: 2254-2265
37. Dominici, M, Le Blanc, K, Mueller, I, Slaper-Cortenbach, I, Marini, F, Krause, D et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317
38. Gronthos, S, Zannettino, AC, Hay, SJ, Shi, S, Graves, SE, Kortesidis, A et al. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116(Pt 9): 1827-1835
39. Bianco, P. and Robey, PG. (2004). Skeletal stem cells. In: Lanza, RP (ed.). Handbook of Adult and Fetal Stem Cells. Academic Press: San Diego, CA. pp. 415-422
40. Gao, J, Dennis, JE, Muzic, RF, Lundberg, M and Caplan, AI (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (Print) 169: 12-20
41. Sekiya, I, Larson, BL, Smith, JR, Pochampally, R, Cui, JG and Prockop, DJ (2002). Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541
42. Sasaki, M, Abe, R, Fujita, Y, Ando, S, Inokuma, D and Shimizu, H (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180: 2581-2587
43. Wang, CH, Cherng, WJ, Yang, NI, Kuo, LT, Hsu, CM, Yeh, HI et al. (2008). Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28: 54-60
44. Meyerrose, TE, De Ugarte, DA, Hofling, AA, Herrbrich, PE, Cordonnier, TD, Shultz, LD et al. (2007). In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25: 220-227
45. Kyriakou, C, Rabin, N, Pizzey, A, Nathwani, A and Yong, K (2008). Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93: 1457-1465
46. Bai, L, Lennon, DP, Eaton, V, Maier, K, Caplan, AI, Miller, SD et al. (2009). Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57: 1192-1203
47. Le Blanc, K, Rasmusson, I, Sundberg, B, Götherström, C, Hassan, M, Uzunel, M et al. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441
48. Westfall, PH and Krishen, A. Optimally weighted, fixed sequence and gatekeeper multiple testing procedures. J Stat Plan Infer 99: 25-40